Standard Versus High Dose ED-Initiated Buprenorphine Induction
Public ClinicalTrials.gov record NCT06494904. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
ED-Initiated Standard Versus High Dose Buprenorphine Induction
Study identification
- NCT ID
- NCT06494904
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Yale University
- Other
- Enrollment
- 360 participants
Conditions and interventions
Conditions
Interventions
- Buprenorphine Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 5, 2024
- Primary completion
- Mar 31, 2027
- Completion
- Nov 30, 2028
- Last update posted
- Apr 24, 2025
2024 – 2028
United States locations
- U.S. sites
- 5
- U.S. states
- 4
- U.S. cities
- 5
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Highland Hospital | Oakland | California | 94602 | Recruiting |
| San Leandro Hospital | San Leandro | California | 94578 | Recruiting |
| Maine Medical Center | Portland | Maine | 04102 | Recruiting |
| Cooper University Hospital | Camden | New Jersey | 08103 | Recruiting |
| University of Utah Hospital | Salt Lake City | Utah | 84132 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06494904, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 24, 2025 · Synced May 9, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06494904 live on ClinicalTrials.gov.